Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0851184 (
thinning
)
11,252
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive and selective loss of motor neurons. Causative genes for familial ALS (fALS), e.g. TARDBP or FUS/TLS, have been found, among which mutations within the
profilin 1
(
PFN1
) gene have recently been identified in ALS18. To elucidate the mechanism whereby
PFN1
mutations lead to neuronal death, we generated transgenic Drosophila melanogaster overexpressing human
PFN1
in the retinal photoreceptor neurons. Overexpression of wild-type or fALS mutant
PFN1
caused no degenerative phenotypes in the retina. Double overexpression of fALS mutant
PFN1
and human TDP-43 markedly exacerbated the TDP-43-induced retinal degeneration, i.e. vacuolation and
thinning
of the retina, whereas co-expression of wild-type
PFN1
did not aggravate the degenerative phenotype. Notably, co-expression of TDP-43 with fALS mutant
PFN1
increased the cytoplasmic localization of TDP-43, the latter remaining in nuclei upon co-expression with wild-type
PFN1
, whereas co-expression of TDP-43 lacking the nuclear localization signal with the fALS mutant
PFN1
did not aggravate the retinal degeneration. Knockdown of endogenous Drosophila
PFN1
did not alter the degenerative phenotypes of the retina in flies overexpressing wild-type TDP-43 These data suggest that ALS-linked
PFN1
mutations exacerbate TDP-43-induced neurodegeneration in a gain-of-function manner, possibly by shifting the localization of TDP-43 from nuclei to cytoplasm.
...
PMID:Familial Amyotrophic Lateral Sclerosis-linked Mutations in Profilin 1 Exacerbate TDP-43-induced Degeneration in the Retina of Drosophila melanogaster through an Increase in the Cytoplasmic Localization of TDP-43. 2763 45